JPH02215706A - Antimicrobial composition and cosmetic - Google Patents

Antimicrobial composition and cosmetic

Info

Publication number
JPH02215706A
JPH02215706A JP1037413A JP3741389A JPH02215706A JP H02215706 A JPH02215706 A JP H02215706A JP 1037413 A JP1037413 A JP 1037413A JP 3741389 A JP3741389 A JP 3741389A JP H02215706 A JPH02215706 A JP H02215706A
Authority
JP
Japan
Prior art keywords
paraben
pionin
composition
cosmetic
cosmetics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1037413A
Other languages
Japanese (ja)
Other versions
JPH0536404B2 (en
Inventor
Masaaki Hayamizu
速水 正明
Yoshinori Nakagawa
美典 中川
Masaaki Seya
瀬谷 昌聡
Hiroshi Hara
弘 原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Kanko Shikiso Kenkyusho KK
Original Assignee
Nippon Kanko Shikiso Kenkyusho KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kanko Shikiso Kenkyusho KK filed Critical Nippon Kanko Shikiso Kenkyusho KK
Priority to JP1037413A priority Critical patent/JPH02215706A/en
Publication of JPH02215706A publication Critical patent/JPH02215706A/en
Publication of JPH0536404B2 publication Critical patent/JPH0536404B2/ja
Granted legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

PURPOSE:To obtain an antimicrobial composition suitable for cosmetic compounding a reduced amount of paraben, having low irritation and safety without lowering antiseptic, antimicrobial and sterilizing effects by blending paraben with pionin. CONSTITUTION:An antimicrobial composition and cosmetic having low irritation containing pionin and paraben. The blending ratio is preferably 0.001-0.005wt.% pionin and 0.02-0.1wt.% paraben. The amount of paraben blended can be reduced to about 1/10, the composition or cosmetic has no problems of solubility and yet has antimicrobial power. Use of both the components shows sufficiently antimicrobial and sterilizing effects on cosmetic contaminating microorganisms.

Description

【発明の詳細な説明】 産業上の利用分野 本発明はピオニンおよびパラベンを含有する低刺激性抗
微生物用組成物および化粧料に関するものである。
DETAILED DESCRIPTION OF THE INVENTION Field of the Invention The present invention relates to hypoallergenic antimicrobial compositions and cosmetics containing pionin and parabens.

從来の技術 從来、化粧品、医薬部外品などの皮膚に使用される化粧
料は多くの場合、皮膚に馴染み易いように設計されてい
る。そのために微生物も繁殖し易く、微生物で汚染され
た化粧料による被害が報告されている。このような化粧
料は多くの化合物の複合剤であり、また近年の現象とし
て数多くの植物、動物からの天然抽出物などが有用成分
として配合され、基剤として微生物の繁殖にとって好環
境を提供している。
BACKGROUND OF THE INVENTION Cosmetics used for the skin, such as cosmetics and quasi-drugs, are often designed to be easily blended into the skin. Therefore, microorganisms are likely to grow, and damage caused by cosmetics contaminated with microorganisms has been reported. Such cosmetics are composite agents of many compounds, and as a recent phenomenon, natural extracts from many plants and animals are included as useful ingredients, and as a base, they provide a favorable environment for the growth of microorganisms. ing.

化粧料には通常この汚染を防ぐために防腐・抗殺菌剤が
配合される。防腐・抗殺菌剤は細胞毒性作用があって微
生物の繁殖を抑えたり(静菌作用)、死滅させたり(殺
菌作用)する作用を示す。ところがこの防腐・抗殺菌剤
は皮膚に対して接触皮膚炎・光接触皮膚炎・アレルギー
・光アレルギーなどの副作用を誘発するなどの問題があ
る。勿論、防腐・抗殺菌剤に限らず他の化粧品原料の中
にも副作用の心配なものもあり、化粧料の安全対策の一
つとして厚生省では「副作用が心配な成分については製
品容器に成分を表示する」義務がもうけられている。(
厚生省公示昭和55年薬発第125号) このリストの中にはパラベン、安息香酸ナトリウム、イ
ソプロピルメチルフェノール、ウンデシレン酸、塩化ベ
ンザルコニウム、デヒドロ酢酸、レゾルシンなど化粧料
に使われる防腐・抗殺菌剤は全て記載されている。
Cosmetics usually contain preservatives and antibacterial agents to prevent this contamination. Preservatives and antibacterial agents have cytotoxic effects and exhibit the effect of suppressing the proliferation of microorganisms (bacteriostatic effect) or killing them (sterilizing effect). However, these preservatives and antibacterial agents have problems such as inducing side effects such as contact dermatitis, photocontact dermatitis, allergies, and photoallergies on the skin. Of course, there are concerns about side effects not only in preservatives and antibacterial agents, but also in other cosmetic ingredients, and as one of the safety measures for cosmetics, the Ministry of Health and Welfare recommends that ingredients with potential side effects be labeled in the product container. There is an obligation to display the information. (
(Ministry of Health and Welfare Public Notice No. 125 of 1980) This list includes preservatives and antibacterial agents used in cosmetics such as parabens, sodium benzoate, isopropylmethylphenol, undecylenic acid, benzalkonium chloride, dehydroacetic acid, and resorcinol. are all listed.

ことに化粧品・医薬部外品などに巾広く繁用されている
代表的な防腐・抗殺菌剤であるパラベン類は02〜2.
0%で期待される効果はあるが、基剤においては溶解性
の悪いこと、パラベンアレルギーがあること、パラベン
による皮膚傷害があることなどの欠点が数多く報告され
ている。その配合量を減らすと安全性も、溶解性も確保
されるが、抗殺菌効果が極度に減少することから、仕方
なく現行濃度で使わせているのが現状である。
In particular, parabens, which are typical preservatives and antibacterial agents widely used in cosmetics and quasi-drugs, are 02-2.
Although it has the expected effects at 0%, many drawbacks have been reported, such as poor solubility in the base, paraben allergy, and skin damage caused by parabens. Reducing the amount added would ensure safety and solubility, but the antibacterial effect would be extremely reduced, so currently we have no choice but to use it at the current concentration.

これらの事から現時点では理想とする防腐・抗殺菌剤は
なく、この様に防腐・抗殺菌剤の最大許容量で対応され
ていることが多い。
For these reasons, there is currently no ideal preservative/antibacterial agent, and as described above, the maximum allowable amount of the preservative/antibacterial agent is often used.

発明が解決しようとする課題 しかしながら化粧品や医薬部外品などの化粧料は経済的
に長年月にわたって連用されること。また化粧料は種々
なる化合物の複合剤であるため、諸因子により著しく防
腐・抗殺菌効果を減衰する場合が多い。例えばpHの影
響、油水分配率によるもの、界面活性剤・高分子化合物
への吸着などがあり、その他に微生物や発育因子として
利用される炭素源、窒素源、塩類、ビタミンなどで生育
のための至適条件を与えている。
Problems to be Solved by the Invention However, cosmetics such as cosmetics and quasi-drugs are economically viable for long-term use. Furthermore, since cosmetics are composite agents of various compounds, their antiseptic and antibacterial effects are often significantly reduced by various factors. For example, there are effects of pH, oil/water partition ratio, adsorption to surfactants and polymer compounds, etc. In addition, microorganisms and carbon sources, nitrogen sources, salts, vitamins, etc. used as growth factors, etc. Provides optimal conditions.

これらのことから少量で安全かつ広範囲の微生物に有効
な防腐・抗殺菌剤の選択を行なうことが不可欠となって
いる。そのため単一化合物に頼るのではなく、基剤条件
に適応して2〜3種の組合せにより少量化をはかり、安
全面と有効性を満たすことに注力されつつある。
For these reasons, it is essential to select antiseptic and antibacterial agents that are safe in small amounts and effective against a wide range of microorganisms. Therefore, instead of relying on a single compound, efforts are being made to reduce the amount by combining two to three types according to the base conditions and to satisfy safety and effectiveness.

理想的な防腐・抗殺菌剤は(1)広い抗菌スペクトルで
あること(2)少量で有害であること(3)充分溶解す
ること(4)生体に対して極力無毒・無刺激で安全性の
高いことなどがあげられる。
The ideal antiseptic/antibacterial agent should (1) have a broad antibacterial spectrum, (2) be harmful in small amounts, (3) be sufficiently soluble, and (4) be as safe as possible, non-toxic and non-irritating to living organisms. Examples include things that are expensive.

業界においては防腐・抗殺菌効果を落さずに、最も多用
されているパラベンの量を減少させることでより安全な
処法をあみ出すことは一つの大きな課題となっている。
A major challenge in the industry is to create safer formulations by reducing the amount of parabens, which are the most commonly used substances, without sacrificing their antiseptic and antibacterial effects.

課題を解決するための手段 この課題を解決するために本発明者らはパラベン配合量
を減少させることとパラベンと相加・相乗作用を示す物
質の検策を行なった。化粧料など皮膚に直接接するもの
は安全でかつ化粧品への配合が許可されている物質でな
ければならない。
Means for Solving the Problems In order to solve this problem, the present inventors reduced the amount of parabens blended and tested substances that exhibit additive or synergistic effects with parabens. Cosmetics and other substances that come into direct contact with the skin must be safe and must be approved for inclusion in cosmetics.

そこで作用は勿論、安全面で数多くの研究が行なわれ、
その安全性から化粧料への配合物質の表示義務を削除さ
れているピオニンに着目して、その併用を試みた。
Therefore, a lot of research has been conducted not only in terms of effectiveness but also in terms of safety.
We focused on pionin, which is no longer required to be labeled as a compounded substance in cosmetics due to its safety, and attempted to use it in combination.

ピオニン(感光素201号)は化粧品の特殊成分として
0.002%以下(医薬部外品として0.005%以下
)で広く配合されており、皮膚に対する安全性も高く、
成分表示義務のない原料である。ピオニンは化粧品の生
産過程での微生物汚染(一次汚染)を防ぐ目的で防腐補
助剤として使うものであるが、化粧品使用時での(二次
汚染)殺菌剤としては使われていない。
Pionin (Photosensor No. 201) is widely used as a special ingredient in cosmetics at 0.002% or less (0.005% or less as a quasi-drug), and is highly safe for the skin.
It is a raw material that is not required to display its ingredients. Pionin is used as a preservative aid to prevent microbial contamination (primary contamination) during the production process of cosmetics, but it is not used as a disinfectant during cosmetic use (secondary contamination).

本発明者らはピオニンを0.001〜0.005重量%
加えることで、保存時・使用時での防腐・抗殺菌効果を
落すことなく、かつ併用するパラベン濃度を從来の常用
量の1/10量と大きく減衰させることを発見して、本
発明を完成した。
The present inventors added 0.001 to 0.005% by weight of pionin.
The present invention was developed based on the discovery that by adding parabens, the concentration of parabens used in combination can be greatly reduced to 1/10 of the conventional amount without reducing the antiseptic and antibacterial effects during storage and use. completed.

本発明により業界の課題であるパラベンの減量が実現で
きたのである。
The present invention has made it possible to reduce the amount of parabens, which has been an issue in the industry.

ここで「化粧料」とは商標法施行規則第四類(石けん類
、歯みがき、化粧品など)に規定するものを言う。
Here, "cosmetics" refers to those stipulated in Class 4 of the Trademark Law Enforcement Regulations (soaps, toothpaste, cosmetics, etc.).

すなわち本発明はピオニンおよびパラベンを含有するこ
とを特徴とする低刺激性抗微生物用組成物および化粧料
に関するものである。
That is, the present invention relates to hypoallergenic antimicrobial compositions and cosmetics characterized by containing pionin and parabens.

本発明により低刺激性微生物用組成物はメイクアップ化
粧品.軟膏.クリーム.ローション.乳液.パック.石
けんなどの基礎化粧品、コンタクトレンズ洗浄剤.同保
存剤.制汗用スプレーなどとして用いることが出来る。
The hypoallergenic composition for microorganisms according to the present invention can be used in makeup cosmetics. ointment. cream. lotion. Emulsion. pack. Basic cosmetics such as soap, contact lens cleaning agents. Same preservative. It can be used as an antiperspirant spray.

作用 本発明はピオニンを0.001〜0.005重量%配合
し、パラベンを0.02〜0.1%配合してなる2剤併
用のものである。
Function The present invention is a two-drug combination product containing 0.001 to 0.005% by weight of pionin and 0.02 to 0.1% of paraben.

ピオニオはこの極微量濃度で殆んどの基剤に溶解し、接
触感作、光感作による異状発現なく、眼の粘膜刺激も至
って軽微であり、pH範囲として生体に影響のない弱酸
性から弱アルカリ性において安定であり、諸種の界面活
性剤中でも安定で何れも効力の失活を見ない。またグラ
ム陽性細菌にも、グラム陰性細菌にも巾広い抗菌スペク
トルを有している。(日本香粧品科学会誌8(NO.1
).P43.1984) 一方、パラベンは現在常用される量である0.1〜1.
0%の濃度では、化粧料基剤への溶解性な困難か、もし
くは不溶のこともある。
Pionio dissolves in most bases at this extremely small concentration, does not cause any abnormalities due to contact sensitization or photosensitization, and causes very slight irritation to the mucous membranes of the eye.The pH range is from weakly acidic to mildly acidic, which has no effect on living organisms. It is stable in alkaline conditions and stable in various surfactants, none of which show any loss of efficacy. It also has a broad antibacterial spectrum against both Gram-positive and Gram-negative bacteria. (Journal of the Japanese Cosmetic Science Society 8 (No. 1)
). P43.1984) On the other hand, parabens are used in the currently commonly used amount of 0.1 to 1.
At a concentration of 0%, it may be difficult to dissolve or even insoluble in cosmetic bases.

そのため油水分配率を油側に傾けるか、または界面活性
剤によるミセル化溶解によることが試みられている。ひ
れでは本来の防腐・抗殺菌効果は望めず基剤の処法に一
工夫も二工夫も必要となる。
Therefore, attempts have been made to tilt the oil-water distribution ratio toward the oil side or to use surfactants to form and dissolve micelles. With fins, the original antiseptic and antibacterial effects cannot be expected, and the formulation of the base requires some ingenuity or two.

またパラベンは経皮吸収性)あり、感作や接触皮膚炎な
どを起し易い、このことは脂溶性配合するこの危険性を
示唆するものである。
Furthermore, parabens are transdermal absorbable (transdermal absorbable) and can easily cause sensitization and contact dermatitis, which suggests the dangers of fat-soluble formulations.

このパラベン配合量を1/10程度に減らすことは、溶
解性も問題なく、添加濃度に応じた抗菌力は期待できる
By reducing the amount of paraben added to about 1/10, there is no problem with solubility and antibacterial activity can be expected depending on the added concentration.

この両者の併用に夫々の特性を生かして添付図表に示す
ごとく期待以上に、化粧料汚染菌としてよく検出される
ブドウ球菌、枯草菌、レンサ球菌、緑膿菌、大腸菌など
に対して充分な抗殺菌力が得られた。
As shown in the attached chart, the combined use of these two products provides sufficient protection against Staphylococcus, Bacillus subtilis, Streptococcus, Pseudomonas aeruginosa, Escherichia coli, etc., which are commonly detected as cosmetic contaminants. Sterilizing power was obtained.

また皮膚常在菌、暫定菌(黄色ブドウ球菌、表皮ブドウ
球菌、枯草菌など)など皮膚上の菌叢の異状は皮膚傷害
を起す最となり、傷害を超すと二次感染症(黄色ブドウ
球菌、緑膿菌、アクネ菌など)につながる。
In addition, abnormalities in the bacterial flora on the skin, such as resident bacteria and temporary bacteria (Staphylococcus aureus, Staphylococcus epidermidis, Bacillus subtilis, etc.), are the most likely to cause skin damage, and if the injury is exceeded, secondary infections (Staphylococcus aureus, Staphylococcus epidermidis, Bacillus subtilis, etc.) (Pseudomonas aeruginosa, P. acnes, etc.).

化粧料はこられ皮膚を清浄化するとともに皮膚菌叢の異
状を起さないようにすることも大切な要素である。ちな
みにピオニンはニキビ起因菌であるアクネ菌に対して抗
殺菌性を有し、ニキビの治癒作用を有することもあり(
日本香粧品科学会詩誌7(NO.3)P250.198
3)化粧料への配合はこの意味からも有用である。
It is important for cosmetics to cleanse the skin and to prevent abnormalities in the skin flora. By the way, pionin has antibacterial properties against acne-causing bacteria, P. acnes, and may also have an acne-healing effect (
Japan Cosmetic Science Society Poetry Journal 7 (NO.3) P250.198
3) Incorporation into cosmetics is also useful in this sense.

次に本発明の実施例および効果をより詳しく説明する。Next, embodiments and effects of the present invention will be described in more detail.

実施例 実施例1 減菌サンプル瓶に処法1のローション20m
lをとり、これに前培養した化粧品由来の緑膿菌液を0
.2ml(107/ml)を加え、ボルテックスミキサ
ーにて充分混和して30℃の恒温器中に保存した。この
試料を毎日一定量採取し、界面活性剤(Twee×n8
0)加、燐酸緩衝液にて希釈したのち、その希釈液をハ
ートインフィジョン寒天培地上に塗り拡げ、37℃、2
4時間培養を行ない、その発生集落を計数して1g(1
ml)当りの生菌数により効果の判定を行なった。
Examples Example 1 20ml of lotion of method 1 in a sterilized sample bottle
1 of Pseudomonas aeruginosa and pre-cultured cosmetic-derived Pseudomonas aeruginosa solution.
.. 2 ml (107/ml) was added, thoroughly mixed with a vortex mixer, and stored in a thermostat at 30°C. A certain amount of this sample was collected every day, and a surfactant (Twee×n8
0) After diluting with phosphate buffer, spread the diluted solution on a heart infusion agar medium and incubate at 37℃ for 2 hours.
Culture was carried out for 4 hours, and the resulting colonies were counted and weighed 1 g (1
The effectiveness was determined based on the number of viable bacteria per ml.

第1図に示すごとくピオニンおよびパラベンの単独添加
では抗殺菌性は弱いか、殆んど認められないものが、本
発明によるピオニンとパラベンの同一濃度の併用添加組
成物では24時間後測定で菌叢は全く認められないすぐ
れた抗殺菌作用を示した。
As shown in Figure 1, when pionin and paraben are added alone, the antibacterial effect is weak or almost non-existent, but when the combined addition composition of pionin and paraben at the same concentration according to the present invention is used, the antibacterial effect is observed after 24 hours. The flora showed excellent antibacterial activity, which was not observed at all.

このことは緑膿菌の107個の起始菌数と言う多量の菌
に対し、夫々の単独では抗菌力を示さない濃度で、2剤
のすぐれた相乗効果を示し少量で強つ抗菌力をもつこと
を意味するものである。
This shows that the two agents have an excellent synergistic effect against a large number of Pseudomonas aeruginosa bacteria (107 starting bacteria) at concentrations that do not exhibit antibacterial activity when used alone. It means to have.

実施例2 前培養した化粧品由来の大腸菌液を起始菌数
106/mlとなるように処法2のローション(乳液)
に加え、実験施例1と同様に試験した。第1表に示すご
とく本発明による併用組成物は大腸菌に対してもすぐれ
た効果を示した。
Example 2 Pre-cultured cosmetic-derived Escherichia coli solution was prepared into lotion (emulsion) according to method 2 so that the number of starting bacteria was 106/ml.
In addition, tests were conducted in the same manner as in Experimental Example 1. As shown in Table 1, the combination composition according to the present invention also showed excellent effects against E. coli.

実施例3 前培養した化粧品由来の緑膿菌液を起始苗数
107/mlとなるように、処法3のクリームに加え、
実施例1と同様に静置培養を行ない試験した。その結課
を第2図に示す。
Example 3 A pre-cultured cosmetic-derived Pseudomonas aeruginosa liquid was added to the cream of Preparation 3 so that the number of starting seedlings was 107/ml,
A static culture was performed and tested in the same manner as in Example 1. The conclusion is shown in Figure 2.

この基剤組成中でも2剤併用の効力が充分に見られた。Even with this base composition, the effectiveness of the combination of the two drugs was sufficiently observed.

実施例4 前培養した化粧品由来の緑膿菌液を起始菌数
107/mlとなるよに処法、4の化粧水に加え、実施
例1と同様に静置培養による停験を行なった。その結果
を第3図に示す。
Example 4 A pre-cultured Pseudomonas aeruginosa liquid derived from cosmetics was prepared to have an initial bacterial count of 107/ml, added to the lotion in Step 4, and subjected to static culture in the same manner as in Example 1. . The results are shown in FIG.

本化粧水は大部分が水であるが、湿潤剤として天然抽出
物を添加してものである。
This lotion is mostly water, but natural extracts are added as humectants.

この影響か、基剤の大部分が水のため溶解性の問題か、
実施例1〜3の効力に比し、やゝ効力が落ちるきらいは
あるが、本発明である2剤の相加効果は示している。
Is this an effect, or is it a solubility problem because most of the base is water?
Although the efficacy tends to be slightly lower than that of Examples 1 to 3, it shows the additive effect of the two drugs of the present invention.

実施例5 前培洋した化粧品由来の枯草菌液を起始菌数
106/mlとなるように処法5のローション(乳液)
に加え、実施例1と同様に試験した。
Example 5 Pre-cultivated Bacillus subtilis solution derived from cosmetics was made into a lotion (emulsion) according to Preparation 5 so that the number of starting bacteria was 106/ml.
In addition, tests were conducted in the same manner as in Example 1.

ここで枯草菌とは枯草、土壌、塵埃など自然界に広く分
布していることから空中浮遊細菌として多く存在する。
Here, Bacillus subtilis is widely distributed in the natural world such as dried grass, soil, and dust, and therefore exists in large numbers as an airborne bacterium.

しかも芽胞をもち抵抗力の強い細菌を言われている。Moreover, it is said to be a highly resistant bacterium that has spores.

本実施例の結果、パラベン単独では抗菌力は弱く、本発
明で用いる低濃度では抗菌効果を示さないが、ピオニン
は単剤でも0.003〜0.005%程度の濃度で抗菌
効果を示した。更に本発明である2剤併用ではピオニン
0.001〜0.002%とパラベン0.03〜0.0
2%の極く低濃度域で充分な抗殺菌力を示した(第4図
)。
As a result of this example, paraben alone has weak antibacterial activity and does not exhibit antibacterial effects at the low concentrations used in the present invention, but pionin alone exhibits antibacterial effects at concentrations of approximately 0.003 to 0.005%. . Furthermore, in the two-drug combination according to the present invention, 0.001 to 0.002% of pionin and 0.03 to 0.0% of paraben are used.
It showed sufficient antibacterial activity at extremely low concentrations of 2% (Figure 4).

実施例6 空中落下細菌曝露試験 防腐剤、抗殺菌剤の一般的な感受性を検討する場合、目
的の薬剤を添加した平板上における落下細菌の消長を観
察する方法がとられる。
Example 6 Exposure test for airborne bacteria When examining the general susceptibility of preservatives and antibacterial agents, a method is used to observe the growth and development of fallen bacteria on a flat plate to which the target agent has been added.

処法6の製品について、その20g(ml)を減菌シャ
ーレにとり、室内に5時間曝露し、空中落下細菌の負荷
を行なった後、30℃恒温器内にて一週間(7日間)、
一定量をハートインフィジョン寒天平板培地に取り培養
した。
Regarding the product of Method 6, 20g (ml) of it was placed in a sterilized petri dish, exposed indoors for 5 hours, loaded with airborne bacteria, and then placed in a 30°C incubator for one week (7 days).
A certain amount was taken and cultured on a heart infusion agar plate medium.

その結果、本発明の組成物を含まない無添加群では何れ
も細菌集落を認めた。その内訳は芽胞菌、グラム陰性菌
、グラム陽性菌、カビであった。それに比し本発明のピ
オニン、パラベンを瓦む試験品にいづれも細菌集落を認
めなかった。
As a result, bacterial colonies were observed in all the additive-free groups that did not contain the composition of the present invention. The breakdown was spore-forming bacteria, gram-negative bacteria, gram-positive bacteria, and molds. In contrast, no bacterial colonies were observed in any of the test products containing pionin and paraben of the present invention.

以下に処法について説明する。The treatment method will be explained below.

処法1 ローシン 油性成分 マイクロクリスタリンワ
ックス 1.0重量% ミツロウ 2.0 ラノリン 
2.0 流動パラフィン 30.0 乳化剤 ソルビタ
ンセスキオレイン酸エステル 4.0 ポリオキシエチ
レンソルビタンモノオレイン酸エステル(20E.O.
) 1.0 ステアリン酸アルミニウム 0.2 香料
 0.4 防腐・抗殺菌剤 本発明組成物 保湿剤 グ
リセリン 8.0 精製水 51.4 処法2 ローション 油性成分 ステアリン酸 2.0
% セタノール 1.5 ワセリン 3.0 ラノリン
アルコール 2.0 流動パラフィン 10.0 乳化
剤 ポリオキシエチレンモノオレイン酸エステル(10
E.O.) 2.0 香剤 0.5 防腐・抗殺菌剤 
本発明組成物 保湿剤 グリセリン 3.0 プロピレ
ングリコール 5.0 アルカリ トリエタノールアミ
ン 1.0 精製水 70.0 処法3 コールドクリーム 油性成分 ベオニールアル
コール 3.0% ミツロウ 4.0 パラフィンワッ
クス 2.5 流動パラフィン 48.0 脂肪酸グリ
セリド 2.0 乳化剤 ポリエチレングリコール脂肪
酸エステル 0.5 グリセリン脂肪酸エステル 1.
0 ポリオキシエチレンソルビタンモノラウリン酸エス
テル(20E.O.) 2.5 ポリオキシエチレンア
ルキルエーテル 1.0 ホウ砂 0.3 香料 0.
2 防腐・抗殺菌剤 本発明組成物 保湿剤 ヒアルロ
ンエキス 0.5 精製水 34.5処法4 化粧水 
エタノール 3.0 可洗化剤 ポリオキシエチレンラ
ウリルエーテル 0.3 保湿剤 グリセリン 0.5
 ピロリドンカルボン酸ナトリウム 1.0 緩衝剤 
クエン酸 0.1 クエン酸ナトリウム 0.2 着香
料 適量 湿潤剤 ビフィズス菌エキス 1.0 ヒア
ルロンエキス 0.5 防腐・抗殺菌剤 本発明組成物
 精製水 93.4 処法5 ローション 油性成分 スクワラン 5.0%
 ワセリン 2.0 ミツロウ 0.5 ラノリンアル
コール 1.5 ステアリン酸 0.3 乳化剤 ソル
ビタンセスキオレイン酸エステル 0.8 ポリオキシ
エチレンオレイルエーテル(20E.O.) 1.2 
香料 0.2 防腐・抗殺菌剤 本発明組成物 保湿剤
 グリセリン 2.0 プロビレングリコール 3.0
 増粘剤 カルボキシビニールポリマー 0.0 精製
水 83.4 処法6 コンタクトレンズ洗浄液 プルラン 2.0%
 ポリオキシエチレンラウリルエーテル 0.5 塩化
ナトリウム 0.6 防腐・抗殺菌剤 本発明組成物 
製精水 96.9 効果 パラベンは化粧料分野で現在防腐・抗殺菌剤として最も
繁用されているが、前述のごとく現在常用の量では多く
の欠点を有し、溶解の点、皮膚刺激、生体への経皮吸収
などで問題が多い。
Recipe 1 Rosin Oil-based component Microcrystalline wax 1.0% by weight Beeswax 2.0 Lanolin
2.0 Liquid paraffin 30.0 Emulsifier Sorbitan sesquioleate 4.0 Polyoxyethylene sorbitan monooleate (20E.O.
) 1.0 Aluminum stearate 0.2 Fragrance 0.4 Preservative/antibacterial agent Composition of the present invention Humectant Glycerin 8.0 Purified water 51.4 Preparation method 2 Lotion Oily component Stearic acid 2.0
% Setanol 1.5 Vaseline 3.0 Lanolin alcohol 2.0 Liquid paraffin 10.0 Emulsifier Polyoxyethylene monooleate (10
E. O. ) 2.0 Fragrance 0.5 Preservative/antibacterial agent
Composition of the present invention Moisturizer Glycerin 3.0 Propylene glycol 5.0 Alkali Triethanolamine 1.0 Purified water 70.0 Method 3 Cold cream Oily component Beonyl alcohol 3.0% Beeswax 4.0 Paraffin wax 2.5 Liquid paraffin 48.0 Fatty acid glyceride 2.0 Emulsifier Polyethylene glycol fatty acid ester 0.5 Glycerin fatty acid ester 1.
0 Polyoxyethylene sorbitan monolaurate (20E.O.) 2.5 Polyoxyethylene alkyl ether 1.0 Borax 0.3 Fragrance 0.
2 Preservative/antibacterial agent Composition of the present invention Moisturizer Hyaluronic extract 0.5 Purified water 34.5 Prescription 4 Lotion
Ethanol 3.0 Detergent Polyoxyethylene lauryl ether 0.3 Humectant Glycerin 0.5
Sodium pyrrolidone carboxylate 1.0 Buffer
Citric acid 0.1 Sodium citrate 0.2 Flavoring agent Appropriate amount Wetting agent Bifidobacteria extract 1.0 Hyaluronic extract 0.5 Preservative/antibacterial agent Composition of the present invention Purified water 93.4 Prescription 5 Lotion Oily component Squalane 5. 0%
Vaseline 2.0 Beeswax 0.5 Lanolin alcohol 1.5 Stearic acid 0.3 Emulsifier Sorbitan sesquioleate 0.8 Polyoxyethylene oleyl ether (20E.O.) 1.2
Fragrance 0.2 Preservative/antibacterial agent Composition of the present invention Humectant Glycerin 2.0 Probylene glycol 3.0
Thickener Carboxyvinyl polymer 0.0 Purified water 83.4 Prescription 6 Contact lens cleaning solution Pullulan 2.0%
Polyoxyethylene lauryl ether 0.5 Sodium chloride 0.6 Preservative/antibacterial agent Composition of the present invention
Purified water 96.9 Effects Parabens are currently most commonly used as preservatives and antibacterial agents in the cosmetics field, but as mentioned above, they have many drawbacks in the amounts currently used, such as dissolution, skin irritation, and There are many problems with transdermal absorption into living organisms.

ピオニンは0.002〜0.005%と言う極く微量で
、抗菌効果があり、低毒性で安全性の高い化合物である
Pionin is a very small amount of 0.002 to 0.005%, has an antibacterial effect, is a low toxicity and highly safe compound.

本発明はこの2つの化合物を併用し、パラベン配合量を
大きく減衰するこで、化粧料などの使用上の安全性を大
きく亢進させ、化粧料などの製造過程、保存時での対微
生物対策と製品の安定性の向上に大きく寄与することが
可能となった。
The present invention uses these two compounds in combination to significantly reduce the amount of parabens added, greatly increasing the safety of cosmetics and other products, and improving anti-microbial measures during the manufacturing process and storage of cosmetics. This has made it possible to greatly contribute to improving product stability.

図面の簡単な説明 第1図 処法1のローション中における本発明組成物と
比較剤の緑膿菌に対する抗殺菌効果 A;本発明組成物
(ピオニン0.005%、パラベン0.05%) B;
本発明組成物(ピオニン0.004%、パラベン0.0
7%) C;本発明組成物(ピオニン0.003%、パ
ラベン0.1%) D;比較剤(無添加) E;比較剤
(パラベン0.05%) F;比較剤(ピオニン0.0
05%) G;比較剤(パラベン0.1%)第2図 処
法3のクリーム中における本発明組成物と比較剤の緑膿
菌に対する抗殺菌効果 A;本発明組成物(ピオニン0
.005%、パラベン0.02%) B;本発明組成物
(ピオニン0.002%、パラベン0.05%) C;
本発明組成物(ピオニン0.002%、パラベン0.0
7%) D;本発明組成物(ピオニン0.002%、パ
ラベン0.03%) E;比較剤(無添加) F;比較
剤(パラベン0.1%) G;比較剤(ピオニン0.0
05%) 第3図 処法4の化粧品中における本発明組成物と比較
剤の緑膿菌に対する抗殺菌効果 A;本発明組成物(ピ
オニン0.002%、パラベン0.1%) B;本発明
組成物(ピオニン0.005%、パラベン0.07%)
 C;本発明組成物(ピオニン0.003%、パラベン
0.07%) D;比較剤(無添加) E;比較剤(ピ
オニン0.002%) F;比較剤(パラベン0.05
%) G;比較剤(ピオニン0.005%)第4図 処
法5のローション中における本発明組成物と比較剤の緑
膿菌に対する抗殺菌効果 A;本発明組成物(ピオニン
0.002%、パラベン0.02%) B;本発明組成
物(ピオニン0.001%、パラベン0.03%) C
;比較剤(ピオニン0.003%) D;比較剤(無添
加) E;比較剤(パラベン0.05%) F;比較剤
(パラベン0.1%)
Brief Description of the Drawings Figure 1 Antibacterial effect of the composition of the present invention and the comparative agent against Pseudomonas aeruginosa in the lotion of Preparation 1 A; Composition of the present invention (0.005% pionin, 0.05% paraben) B ;
Composition of the present invention (pionin 0.004%, paraben 0.0
7%) C: Composition of the present invention (Pionin 0.003%, Paraben 0.1%) D: Comparative agent (no addition) E: Comparative agent (paraben 0.05%) F: Comparative agent (Pionin 0.0
05%) G: Comparative agent (paraben 0.1%) Figure 2 Antibacterial effects of the composition of the present invention and the comparative agent against Pseudomonas aeruginosa in the cream of Prescription 3 A: Composition of the present invention (paraben 0.1%)
.. 005%, paraben 0.02%) B; Composition of the present invention (pionin 0.002%, paraben 0.05%) C;
Composition of the present invention (pionin 0.002%, paraben 0.0
7%) D: Composition of the present invention (Pionin 0.002%, Paraben 0.03%) E: Comparative agent (no addition) F: Comparative agent (paraben 0.1%) G: Comparative agent (Pionin 0.0
05%) Fig. 3 Antibacterial effects of the composition of the present invention and comparative agents against Pseudomonas aeruginosa in cosmetics of Method 4 A: Composition of the present invention (0.002% pionin, 0.1% paraben) B: Main Invention composition (0.005% pionin, 0.07% paraben)
C: Composition of the present invention (0.003% pionin, 0.07% paraben) D: Comparative agent (no addition) E: Comparative agent (0.002% pionin) F: Comparative agent (0.05 paraben
%) G: Comparative agent (0.005% pionin) Figure 4 Antibacterial effects of the composition of the present invention and the comparative agent against Pseudomonas aeruginosa in the lotion of Prescription 5 A: Composition of the present invention (0.002% pionin) , paraben 0.02%) B; Composition of the present invention (pionin 0.001%, paraben 0.03%) C
; Comparative agent (Pionin 0.003%) D; Comparative agent (no additive) E; Comparative agent (paraben 0.05%) F; Comparative agent (paraben 0.1%)

Claims (3)

【特許請求の範囲】[Claims] (1)ピオニンおよびパラベンを含有することを特徴と
する低刺激性抗微生物組成物
(1) Hypoallergenic antimicrobial composition characterized by containing pionin and parabens
(2)ピオニン0.001〜0.005重量%およびパ
ラベン0.002〜0.1重量%を含有することを特徴
とする特許請求の範囲第1項記載の組成物
(2) The composition according to claim 1, which contains 0.001 to 0.005% by weight of pionin and 0.002 to 0.1% by weight of parabens.
(3)ピオニンおよびパラベンを含有することを特徴と
する化粧料
(3) Cosmetics characterized by containing pionin and parabens
JP1037413A 1989-02-16 1989-02-16 Antimicrobial composition and cosmetic Granted JPH02215706A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1037413A JPH02215706A (en) 1989-02-16 1989-02-16 Antimicrobial composition and cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1037413A JPH02215706A (en) 1989-02-16 1989-02-16 Antimicrobial composition and cosmetic

Publications (2)

Publication Number Publication Date
JPH02215706A true JPH02215706A (en) 1990-08-28
JPH0536404B2 JPH0536404B2 (en) 1993-05-31

Family

ID=12496838

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1037413A Granted JPH02215706A (en) 1989-02-16 1989-02-16 Antimicrobial composition and cosmetic

Country Status (1)

Country Link
JP (1) JPH02215706A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001048781A (en) * 1999-08-09 2001-02-20 Taisho Pharmaceut Co Ltd Composition for external use
JP2007269813A (en) * 1998-02-24 2007-10-18 Hayashibara Biochem Lab Inc Antiseptic sterilizer, and composition for application to human body
JP2011074082A (en) * 1998-02-24 2011-04-14 Hayashibara Biochem Lab Inc Antiseptic sterilizer and composition for application to human body
JP5145214B2 (en) * 2006-05-11 2013-02-13 株式会社林原 Disinfectant / preservative
JP2020522482A (en) * 2017-06-02 2020-07-30 ズレックス ファーマ,インコーポレイテッド Low alcohol and sterilizable antibacterial composition and use thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007269813A (en) * 1998-02-24 2007-10-18 Hayashibara Biochem Lab Inc Antiseptic sterilizer, and composition for application to human body
JP2011074082A (en) * 1998-02-24 2011-04-14 Hayashibara Biochem Lab Inc Antiseptic sterilizer and composition for application to human body
JP4734293B2 (en) * 1998-02-24 2011-07-27 株式会社林原生物化学研究所 Antiseptic disinfectant and human body composition
JP2001048781A (en) * 1999-08-09 2001-02-20 Taisho Pharmaceut Co Ltd Composition for external use
JP5145214B2 (en) * 2006-05-11 2013-02-13 株式会社林原 Disinfectant / preservative
JP2020522482A (en) * 2017-06-02 2020-07-30 ズレックス ファーマ,インコーポレイテッド Low alcohol and sterilizable antibacterial composition and use thereof

Also Published As

Publication number Publication date
JPH0536404B2 (en) 1993-05-31

Similar Documents

Publication Publication Date Title
JP4176227B2 (en) Antimicrobial composition
US4921694A (en) Deodorizing and antimicrobial composition for use in cosmetic or topical formulations
EP1278420B1 (en) Antimicrobial composition formulated with essential oils
US6187327B1 (en) Antimicrobial sanitizing lotion with skin protection properties
US20030139307A1 (en) Sanitizing hand cleanser
JPH06509564A (en) antibacterial mixture
EP1699529A1 (en) Antimicrobial compositions containing an aromatic carboxylic acid and a hydric solvent
TW201002201A (en) Preservative blends containing quaternary ammonium compounds
JP5637987B2 (en) Preservative composition
WO2007103441A2 (en) Antimicrobial esters
JP2011074082A (en) Antiseptic sterilizer and composition for application to human body
KR102272901B1 (en) Composition for external application to the skin containing meso-2,3-butanediol as a preservative
JP5346455B2 (en) Antibacterial detergent composition
JPH06157278A (en) Skin external preparation for acne vulgaris
JPH02215706A (en) Antimicrobial composition and cosmetic
JP4999321B2 (en) Drugs containing antiseptic disinfectant and antiseptic disinfection method
JP4734293B2 (en) Antiseptic disinfectant and human body composition
WO2016064180A1 (en) Composition containing meso-2,3-butanediol
KR102482158B1 (en) gel composition for disinfection and manufacturing method thereof
JP2006083111A (en) Disinfecting composition
JP2004352635A (en) Composition for disinfection and/or sterilization
RU2409367C2 (en) Prophylactic agent for skin with antituberculous effect
JP7475210B2 (en) Leave-on disinfectant composition
KR102567219B1 (en) Composition for depilating with disinfecting
KR102442630B1 (en) Disinfectant composition targeting nosocomial pathogens based on low-concentration ethanol and natural antimicrobial synergism

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090531

Year of fee payment: 16

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090531

Year of fee payment: 16